Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

45.78 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 45.78
Bid (Size) 44.86 (2)
Ask (Size) 46.70 (1)
Prev. Close 45.78
Today's Range 45.78 - 45.78
52wk Range 34.37 - 81.72
Shares Outstanding 170,341,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates

Performance

YTD
+0.73%
+0.73%
1 Month
+0.31%
+0.31%
3 Month
+13.51%
+13.51%
6 Month
-31.58%
-31.58%
1 Year
-37.06%
-37.06%

More News

Read More
Catalent Appoints David McErlane as Biologics Segment Leader
From Catalent, Inc.
Via Business Wire
15 Analysts Have This to Say About Catalent
Via Benzinga
Catalent Earnings Preview
Via Benzinga
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
From Catalent, Inc.
Via Business Wire
3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late
Via InvestorPlace
Topics Stocks
Exposures US Equities
Catalent, Inc. to Present at September Investor Conferences
From Catalent, Inc.
Via Business Wire
Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
Via Benzinga
Why Catalent Stock Zoomed 12% Higher This Week
Via The Motley Fool
Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says
Via Benzinga
RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know
Via Benzinga
Why Catalent Stock Surged Nearly 5% Higher Today
Via The Motley Fool
Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count
Via InvestorPlace
Can a New CFO Save Canoo (GOEV) Stock?
Via InvestorPlace
ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Catalent (CTLT) Stock Gains on Elliott Deal
Via InvestorPlace
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
Via Benzinga
Exposures COVID-19
Catalent Announces Governance Enhancements and New Initiatives to Drive Value
From Catalent, Inc.
Via Business Wire
Catalent, Inc. Reports Preliminary Fourth Quarter and Fiscal 2023 Results
From Catalent, Inc.
Via Business Wire
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
Via Benzinga
Why Novo Nordisk Stock Was Racing Higher on Wednesday
Via The Motley Fool
One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.